FRAX™ and the assessment of fracture probability in men and women from the UK
By J. Kanis, O. Johnell, A. Odén, H. Johansson, Eugene V. McCloskey. Osteoporosis International, 2008
2,460 citations recorded by the source corpus.
SummaryA fracture risk assessment tool (FRAX™) is developed based on the use of clinical risk factors with or without bone mineral density tests applied to the UK.IntroductionThe aim of this study was to apply an assessment tool for the prediction of fracture in men and women with the use of clinical risk factors (CRFs) for fracture with and without the use of femoral neck bone mineral density (BMD). The clinical risk factors, identified from previous meta-analyses, comprised body mass index (BMI, as a continuous variable), a prior history of fracture, a parental history of hip fracture, use of oral glucocorticoids, rheumatoid arthritis and other secondary causes of osteoporosis, current smoking, and alcohol intake 3 or more units daily.MethodsFour models were constructed to compute fracture probabilities based on the epidemiology of fracture in the UK. The models comprised the ten-year probability of hip fracture, with and without femoral neck BMD, and the ten-year probability of a major osteoporotic fracture, with and without BMD. For each model fracture and death hazards were computed as continuous functions.ResultsEach clinical risk factor contributed to fracture probability. In the absence of BMD, hip fracture probability in women with a fixed BMI (25 kg/m2) ranged from 0.2% at the age of 50 years for women without CRF’s to 22% at the age of 80 years with a parental history of hip fracture (approximately 100-fold range). In men, the probabilities were lower, as was the range (0.1 to 11% in the examples above). For a major osteoporotic fracture the probabilities ranged from 3.5% to 31% in women, and from 2.8% to 15% in men in the example above. The presence of one or more risk factors increased probabilities in an incremental manner. The differences in probabilities between men and women were comparable at any given T-score and age, except in the elderly where probabilities were higher in women than in men due to the higher mortality of the latter.ConclusionThe models provide a framework which enhances the assessment of fracture risk in both men and women by the integration of clinical risk factors alone and/or in combination with BMD.
Subfields: Molecular Biology, Orthopedics and Sports Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/868957cf3f4e988c3b4d74aa7bfd6125788e6dfb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- J. Kanis
- Eugene V. McCloskey
- H. Johansson
- Chris Cooper
- R. Rizzoli
- J. Reginster
- on behalf of the International Osteoporosis Foundation
In Orthopedics and Sports Medicine
- J. Kanis
- Chris Cooper
- J. Reginster
- Eugene V. McCloskey
- H. Johansson
- R. Rizzoli
- on behalf of the International Osteoporosis Foundation
- A. Odén
In Surgery
- J. Kanis
- Eugene V. McCloskey
- Chris Cooper
- J. Reginster
- H. Johansson
- R. Rizzoli
- A. Odén
- on behalf of the International Osteoporosis Foundation
Citations in the corpus
- FRAX and its applications to clinical practice. (2009, methodology): “Fracture probabilities were computed using the FRAX tool calibrated to the epidemiology of fracture and death in the UK [1].”
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, methodology): “uk/FRAX) that calculates the 10-year probability of a major fracture (hip, clinical spine, humerus or wrist fracture) and the 10-year probability of hip fracture [8, 75, 76].”
- Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study (2011, background): “Hip fractures and major osteoporotic fractures (ie, hip, clinical spine, forearm, and humerus fractures) were studied because these are the basis for the 10-year absolute fracture risk estimates published by Kanis and colleagues.((31,32)) We required that hip and forearm fractures be accompanied by ”
- The clinician’s guide to prevention and treatment of osteoporosis (2022, background): “Developers of FRAX® determined that for many secondary causes of osteoporosis, fracture risk is mediated primarily through impact on BMD [77].”
- Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK (2008, methodology): “The FRAX algorithms provide two outputs; namely the 10-year probability of a major osteoporotic fracture (spine, hip, forearm or humerus) and the 10-year probability of a hip fracture [11].”
- Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia (2014, background): “Tools assessing fracture risk (such as FRAX) [281,282] are not designed or validated for this patient group, and therefore are not suitable for guiding treatment decisions.”